Have you ever wondered whether ApoE4’s harmful effects come from a loss of function--or a toxic gain of function?
It’s a crucial question, especially for researchers deciding whether to suppress ApoE4… or boost it.

This video breaks down the latest findings from the Alzheimer’s Association International Conference on APOE and Lipid Biology (March 2025)

You’ll learn about:

- Human case studies where partial or total APOE loss delayed or prevented Alzheimer’s
- Why microglial APOE4 may be the real trigger—and how targeting it could shift the disease
- How ASOs, gene knockdowns, and precision therapies may soon rewire brain inflammation and amyloid buildup

This isn’t theoretical—these are real, actionable findings that could inform your prevention protocol right now.

If you like it, please remember to hit subscribe and hit the notification bell on Youtube so you don’t miss any of my future videos.
I am going to post a video series that dissect all the latest Research updates that happened at
1) The Alzheimer’s Association International Conference on APOE and Lipid Biology (March 2025)
2) AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (April 2025)